https://ve-821inhibitor.com/di....fferential-appearanc
Results We didn't discover variations in the risk of mortality, ischaemic stroke or any gastrointestinal bleeding. Nevertheless, we did discover a reduced danger of intracranial haemorrhage for dabigatran (HR 0.34, 95%CI0.20-0.56) and rivaroxaban (HR0.55, 95%CI0.35-0.85) when compared to acenocoumarol. In sub-analyses, apixaban revealed a higher risk of ischaemic swing in high-risk people (≥75y and CHA2DS2-VASC rating ≥ 2). Conclusions No differences in medic
Like
Comment
Share
